• Je něco špatně v tomto záznamu ?

Estimation of competitive antagonist affinity by the Schild method and from functional inhibition curves using a novel form of the Gaddum equation

M. Ezechiáš, T. Cajthaml,

. 2019 ; 420 (-) : 21-28. [pub] 20190329

Jazyk angličtina Země Irsko

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023946

The equilibrium dissociation constant of competitive antagonists represents the affinity of the receptor-ligand interaction, and it is a key characteristic of many therapeutic drugs or toxic compounds. Two commonly used methods by which the affinity of the antagonist can be estimated are Schild analysis and the Cheng-Prusoff method. However, both methods yield different results when applied to systems with slopes not equal to one. The Gaddum equation, which is fundamental for both methods, should be extended to incorporate the slope parameter of the dose-response curves and this extension should diminish the differences between the Schild and Cheng-Prusoff methods. In this study, we derived a novel form of the Gaddum equation with a slope parameter (Hill coefficient) of agonist dose-response curve. We also derived the subsequent equations for Schild and Cheng-Prusoff analysis and we validated the proposed model by the measurement of several known estrogen receptor competitive antagonists. Standardized in vitro yeast reporter gene assay (BMAEREluc/ERα) has been used for the measurements and the range of used antagonist concentrations was 1.37-46.03 μM. By applying our mathematical model, both Schild and Cheng-Prusoff methods provide more similar values of antagonist affinity than the original mathematical approach. The correctness of the model has also been demonstrated by the measurement of a partial agonist with a known receptor affinity. The presented mathematical model significantly reduces the differences in values calculated by the Cheng-Prusoff and Schild methods and yields more accurate estimations of antagonist affinity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023946
003      
CZ-PrNML
005      
20201214131851.0
007      
ta
008      
201125s2019 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.tox.2019.03.015 $2 doi
035    __
$a (PubMed)30935971
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Ezechiáš, Martin $u Laboratory of Environmental Biotechnology, Institute of Microbiology of the CAS, v.v.i., Vídeňská 1083, Prague, 142 20, Czech Republic. Electronic address: ezechias@biomed.cas.cz.
245    10
$a Estimation of competitive antagonist affinity by the Schild method and from functional inhibition curves using a novel form of the Gaddum equation / $c M. Ezechiáš, T. Cajthaml,
520    9_
$a The equilibrium dissociation constant of competitive antagonists represents the affinity of the receptor-ligand interaction, and it is a key characteristic of many therapeutic drugs or toxic compounds. Two commonly used methods by which the affinity of the antagonist can be estimated are Schild analysis and the Cheng-Prusoff method. However, both methods yield different results when applied to systems with slopes not equal to one. The Gaddum equation, which is fundamental for both methods, should be extended to incorporate the slope parameter of the dose-response curves and this extension should diminish the differences between the Schild and Cheng-Prusoff methods. In this study, we derived a novel form of the Gaddum equation with a slope parameter (Hill coefficient) of agonist dose-response curve. We also derived the subsequent equations for Schild and Cheng-Prusoff analysis and we validated the proposed model by the measurement of several known estrogen receptor competitive antagonists. Standardized in vitro yeast reporter gene assay (BMAEREluc/ERα) has been used for the measurements and the range of used antagonist concentrations was 1.37-46.03 μM. By applying our mathematical model, both Schild and Cheng-Prusoff methods provide more similar values of antagonist affinity than the original mathematical approach. The correctness of the model has also been demonstrated by the measurement of a partial agonist with a known receptor affinity. The presented mathematical model significantly reduces the differences in values calculated by the Cheng-Prusoff and Schild methods and yields more accurate estimations of antagonist affinity.
650    _2
$a zvířata $7 D000818
650    _2
$a benzhydrylové sloučeniny $x metabolismus $x toxicita $7 D001559
650    _2
$a kompetitivní vazba $7 D001667
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a parciální agonismus léků $7 D054333
650    _2
$a endokrinní disruptory $x metabolismus $x toxicita $7 D052244
650    _2
$a estradiol $x metabolismus $x farmakologie $7 D004958
650    _2
$a antagonisté estrogenového receptoru $x metabolismus $x farmakologie $7 D065171
650    _2
$a alfa receptor estrogenů $x antagonisté a inhibitory $x metabolismus $7 D047628
650    _2
$a estrogeny $x metabolismus $x farmakologie $7 D004967
650    _2
$a lidé $7 D006801
650    _2
$a ligandy $7 D008024
650    12
$a biologické modely $7 D008954
650    _2
$a fenoly $x metabolismus $x toxicita $7 D010636
650    _2
$a vazba proteinů $7 D011485
650    _2
$a reprodukovatelnost výsledků $7 D015203
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Cajthaml, Tomáš $u Laboratory of Environmental Biotechnology, Institute of Microbiology of the CAS, v.v.i., Vídeňská 1083, Prague, 142 20, Czech Republic; Institute for Environmental Studies, Faculty of Science, Charles University in Prague, Albertov 6, Prague, 128 43, Czech Republic.
773    0_
$w MED00004533 $t Toxicology $x 1879-3185 $g Roč. 420, č. - (2019), s. 21-28
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30935971 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214131851 $b ABA008
999    __
$a ok $b bmc $g 1596265 $s 1114622
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 420 $c - $d 21-28 $e 20190329 $i 1879-3185 $m Toxicology $n Toxicology $x MED00004533
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...